Takeda: Hypoparathyroidism trials

The registry lists 12 Hypoparathyroidism studies with Takeda as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 2Phase 3 6Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy Study of rhPTH(1-84) in Subjects With HypoparathyroidismTerminatedNCT03364738Phase 3Results posted
• A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)CompletedNCT03324880Phase 4Results posted
• Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult SubjectsCompletedNCT03150108Phase 1Results posted
• A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in HypoparathyroidismCompletedNCT02910466Phase 4Results posted
• Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With HypoparathyroidismCompletedNCT02781844Phase 1Results posted
• A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in HungaryCompletedNCT01455181Phase 3Results posted
• A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)CompletedNCT01297309Phase 3Results posted
• Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)CompletedNCT01268098Phase 3Results posted
• Use of NPSP558 in the Treatment of HypoparathyroidismCompletedNCT00732615Phase 3Results posted
• A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARACompletedNCT05556629
• A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic HypoparathyroidismWithdrawnNCT03878953Phase 3
• A Registry for Participants With Chronic HypoparathyroidismCompletedNCT01922440